AI in Drug Discovery Market Share to Grow At 29.6% CAGR, To Hit USD 35.42 Billion by 2034 | PMR
17. Dezember 2024 03:04 ET
|
Polaris Market Research & Consulting LLP
New York, USA, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Market Figures The global AI in drug discovery market size was USD 1.99 billion in 2024, estimated at USD 2.65 billion in 2025, and is expected to...
AI Driven Drug Discovery Patent Landscape Report 2024: Comprehensive Patent Landscape for AI-driven Drug Discovery, Analyzing 1,087 Patents from 2002 to 2024
16. Dezember 2024 12:27 ET
|
Research and Markets
Dublin, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The "AI Driven Drug Discovery Patent Landscape Report 2024" report has been added to ResearchAndMarkets.com's offering. The report provides a...
Bioinformatics Market Size to Hit USD 35.38 Billion by 2032, Driven by Increasing Demand for Personalized Medicine and Advanced Biological Data Analysis | SNS Insider
11. Dezember 2024 07:28 ET
|
SNS Insider pvt ltd
Austin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Bioinformatics Market Size Analysis: “According to SNS Insider, The Bioinformatics Market Size was valued at USD 11.45 billion in 2023 and is projected to...
Pharmaceutical Regulatory Affairs in China - 2 Day Online Training Course (March 31, 2025 April 1, 2025)
10. Dezember 2024 13:01 ET
|
Research and Markets
Dublin, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in China Training Course" has been added to ResearchAndMarkets.com's offering. This seminar will provide an...
Leapfrog Bio Presents Novel Genetic Sensitizing Mutation Linked to BET Inhibitors and Clinical Development Plans for Lead Product Candidate at the AACR Special Conference in Cancer Research
10. Dezember 2024 08:00 ET
|
Leapfrog Bio
Leapfrog Bio announced AACR presentation describing the discovery, characterization, and clinical development plan for lead drug LFB-190.
Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis
10. Dezember 2024 07:00 ET
|
Relation Therapeutics
FOR IMMEDIATE RELEASERelation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis London, UK, December 10, 2024 – Relation, an industry...
Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis
10. Dezember 2024 02:00 ET
|
Relation Therapeutics
Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis London, UK, December 10, 2024 – Relation, an industry leader in deploying...
Pattern Announces Partnership with Phenome Health
06. Dezember 2024 14:07 ET
|
PATTERN COMPUTER, INC.
REDMOND, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced that it has entered into a multi-target partnership with Phenome Health, a...
SoftServe Unveils New Gen AI Solution ‘Drug Discovery,’ Built with NVIDIA Blueprints at AWS re:Invent 2024
03. Dezember 2024 13:31 ET
|
SoftServe
AUSTIN, Texas, Dec. 03, 2024 (GLOBE NEWSWIRE) -- SoftServe, a premier IT consulting and digital services provider, today announced the debut of its newest Generative AI (Gen AI) solution, Drug...
Inhalable Drug Delivery Pipeline Report 2024: Stages of Development, Segments, Region & Countries, Regulatory Path and Key Companies
27. November 2024 08:03 ET
|
Research and Markets
Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The "Inhalable Drug Delivery Pipeline: Stages of Development, Segments, Region & Countries, Regulatory Path and Key Companies, 2024 Update" report has...